Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

145.59
+9.266.79%
Post-market: 144.00-1.5900-1.09%19:55 EDT
Volume:1.80M
Turnover:256.01M
Market Cap:9.13B
PE:-65.31
High:145.93
Open:138.43
Low:135.05
Close:136.33
52wk High:145.93
52wk Low:23.30
Shares:62.71M
Float Shares:61.76M
Volume Ratio:0.96
T/O Rate:2.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:20.48
PE(LYR):-112.11

Loading ...

Twist Bioscience grants 115,279 inducement equity awards to newly hired employees

Reuters
·
May 05

Twist Bioscience (TWST) Gets a Buy from Guggenheim

TIPRANKS
·
May 05

Leerink Upgrades Twist Bioscience to Outperform From Market Perform, Adjusts Price Target to $70 From $55

MT Newswires Live
·
May 05

Twist Bioscience : Barclays Raises Target Price to $65 From $55

THOMSON REUTERS
·
May 05

Twist Bioscience upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
May 05

Twist Bioscience Corp : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $70 From $55

THOMSON REUTERS
·
May 05

Twist Bioscience Corp : TD Cowen Raises Target Price to $68 From $58

THOMSON REUTERS
·
May 05

Twist Bioscience price target raised to $65 from $55 at Barclays

TIPRANKS
·
May 05

Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss

Stock Track
·
May 04

Twist Bioscience Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Twist Bioscience Outlook FY Revenue USD 442-447 Million

THOMSON REUTERS
·
May 04

Twist Bioscience FY26 Q2 net loss widens to $44 million; revenue rises 19% to $110.7 million

Reuters
·
May 04

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal Q3 Revenue Range $114M to $115M, vs. FactSet Est of $111.3M

MT Newswires Live
·
May 04

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q2 Loss $0.71 a Share, vs. FactSet Est of $0.50 Loss

MT Newswires Live
·
May 04

Twist Bioscience posts fiscal 2026 Q2 earnings report, investor presentation online

Reuters
·
May 04

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Outlook Q3 Total Revenue of Approximately $114 Million to $115 Million

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Q3 REV View $111.4 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 04

Twist Bioscience director Melissa Starovasnik sells 500 shares worth $30,915

Reuters
·
Apr 30

Earning Preview: Twist Bioscience Corp revenue expected to increase by 17.03% this quarter, and institutional views are bullish

Earnings Agent
·
Apr 27